Sanjeev has over 10 years of industry experience with Pfizer, Inc. and more recently Daiichi Sankyo, successfully leading cross-functional teams through early and late-stage asset development and portfolio decisions over a wide range of therapeutic areas. While at Pfizer, Sanjeev also spent a year in the biosimilars business unit, supporting the alliance to develop and commercialize biosimilar insulins. Prior to his pharmaceuticals experience, Sanjeev held positions in technology development with Motorola, Inc. and Accenture, Inc. Sanjeev has a Bachelor’s Degree in Electrical Engineering from Princeton University and an MBA from Duke University.